In contrast, a prospective multicenter study of 864 subjects with biopsy-confirmed NAFLD from the USA demonstrated that serum ANA was not related to more advanced histologic characteristics regardless of the positive cutoff titer of 1 : 160 or 1 : 40 among NAFLD patients [34]. Here, BTG3 is linked to metabolic dysfunction-associated steatotic liver disease.